KAMES CAPITAL plc

Position in LLY — ELI LILLY & Co

CIK 1539994 EDINBURGH, X0

Position in LLY

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$97,185,023

+$38,328,021 QoQ

Shares Held

81,026

+26.6% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

1.07%

of 13F equity value

Holder Rank

#12

of 437 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 98.54984819687508.ToString("F0")% Shared 0.ToString("F0")% None 1.4501518031249228.ToString("F0")%

Healthcare · as of Jun 30, 2026

KAMES CAPITAL plc holds $1,010,877,249 across 9 Drug Manufacturers - General names. LLY ranks #5 (9.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	1,905,111	$361,247,147
2	ABBV	AbbVie Inc.	680,730	$171,298,897
3	MRK	Merck & Co., Inc.	1,169,722	$150,309,277
4	JNJ	Johnson & Johnson	443,703	$112,687,250
5	LLY	ELI LILLY & Co This page	81,026	$97,185,023
6	BIIB	Biogen Inc.	241,101	$52,092,282
7	BMY	Bristol Myers Squibb Co	635,252	$36,603,220
8	GILD	Gilead Sciences, Inc.	192,146	$24,275,725

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$97,185,023	81,026	+26.6%	Shares	Sole	2026-07-13
2026-03-31	$58,857,002	63,991	-5.0%	Shares	Sole	2026-04-16
2025-12-31	$72,357,136	67,329	+35.1%	Shares	Sole	2026-01-29
2025-09-30	$38,038,602	49,854	-27.5%	Shares	Sole	2025-10-31
2025-06-30	$53,607,498	68,769	-3.5%	Shares	Sole	2026-04-10
2025-03-31	$58,841,132	71,244	-5.4%	Shares	Sole	2026-04-10
2024-12-31	$58,163,252	75,341	-3.6%	Shares	Sole	2026-04-10
2024-09-30	$69,268,104	78,186	+0.9%	Shares	Sole	2026-04-10
2024-06-30	$70,146,126	77,477	+25.2%	Shares	Sole	2026-04-10
2024-03-31	$48,160,391	61,906	+694.2%	Shares	Sole	2026-04-10
2023-12-31	$4,543,861	7,795	—	Shares	Sole	2026-04-10
No filing history on record for this holder in this stock.